(18)FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study

BACKGROUND: Pathologic response to neoadjuvant chemotherapy (neoCTX) is a prognostic factor in many cancer types, and early prediction would help to modify treatment. In patients with gastric and esophagogastric junction (AEG) cancer, the accuracy of FDG PET-CT to predict early pathologic response a...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Paul M., Eshmuminov, Dilmurodjon, Rordorf, Tamara, Vetter, Diana, Veit-Haibach, Patrick, Weber, Achim, Bauerfeind, Peter, Samaras, Panagiotis, Lehmann, Kuno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944162/
https://www.ncbi.nlm.nih.gov/pubmed/29743108
http://dx.doi.org/10.1186/s12885-018-4477-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944162/
https://www.ncbi.nlm.nih.gov/pubmed/29743108
http://dx.doi.org/10.1186/s12885-018-4477-4

Ejemplares similares